Mitral regurgitation affects more than 2 million people in the USA. The main causes are
classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of …

Background Mitral regurgitation is the most common valve disease worldwide but whether
the community-wide prevalence, poor patient outcomes, and low rates of surgical treatment …

Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Background The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and
the treatment is uncertain. We studied the effect on the outcome of quantifying mitral …

Key Clinical Points Secondary Mitral Regurgitation Mitral regurgitation can be broadly
classified into two different categories—primary and secondary mitral regurgitation. The …

The field of mitral valve disease diagnosis and management is rapidly changing. New
understanding of disease pathology and progression, with improvements in and increased …

Over the past two decades interest in mitral valve regurgitation has increased as a result of
the development of new technologies that have expanded the number of patients who can …

Background Ischemic mitral regurgitation is associated with increased mortality and
morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral …

The optimal surgical strategy for the management of ischemic mitral regurgitation (IMR) is
still debated. The purpose of this study was to perform a meta-analysis summarizing the …

Background Mitral regurgitation (MR) is a common valvular disorder, occurring in up to 10%
of the general population. Although surgery is the established treatment for primary MR …